TABLE 5.

ORs and 95% CI for Predictors of Adherence Based on Medication Monitoring Adjusted for Active Inflammation (FCAL), Active IBD Symptoms (IBDSI), Disease Type, Sex, Perceived Stress, and Age

Variable	Adjusted Regression Adherence >90% OR (95% CI)†	P*	Unadjusted Regression Adherence >90% OR (95% CI)	P*	Unadjusted Regression Adherence >80% OR (95% CI)	P*
Active inflammation (FCAL >250 µg/g)	1.04 (0.35-3.11)	0.72	0.84 (0.32-2.2)	0.72	1.58 (0.44-5.75)	0.48
High perceived stress (CPSS >8)	0.67 (0.19-2.32)	0.50	0.69 (0.24-2.01)	0.50	1.48 (0.30-7.31)	0.63
Active IBD symptoms IBDSI >13, UC; >14, CD	0.44 (0.13-1.45)	0.14	0.45 (0.16-1.30)	0.14	0.63 (0.17-2.40)	0.50
CD	4.62 (1.36-15.7)	0.01	2.58 (0.93-7.15)	0.07	4.15 (1.09-15.9)	0.04
Female	0.39 (0.10-1.53)	0.15	0.38 (0.10-1.41)	0.15	0.23 (0.03-1.84)	0.17
Age, y (ref <45):
45-54	3.08 (0.62-15.29)	0.17	2.10 (0.54-8.22)		1.63 (0.25-10.58)
≥55	2.37 (0.65-8.65)	0.19	1.86 (0.61-5.70)	0.27	1.06 (0.24-4.61)	0.94
Smoking	1.22 (0.22-6.87)	0.23	1.77 (0.37-8.47)	0.47	1.90 (0.22-15.93)	0.55

*P values in bold represent statistical significance.

^†C-statistic = 0.712.